Abiopharma

(10% Negative) Leap Therapeutics, Inc. (LPTX) Announces Delay in disclosed Development Timeline Due to Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Regulatory Update

(99% Neutral) FULCRUM THERAPEUTICS, INC. (FULC) Announces Executive Departure

(93% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) Genmab (GMAB) Files Form 6-K

(99% Positive) IONIS PHARMACEUTICALS, INC. (IONS) Provides Update on patients for a range of unmet medical needs

(10% Negative) Aquestive Therapeutics, Inc. (AQST) Announces Delay in study Trials for its AQST-109 epinephrine oral film Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) SAB BIOTHERAPEUTICS, INC. (SABS) Files Form 8-K

(90% Positive) VERTEX PHARMACEUTICALS INC / MA (VRTX) Provides Update on million for T1D is shared by

(19% Negative) INNOVIVA, INC. (INVA) Announces Business Combination